HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changzheng Chen Selected Research

Levomilnacipran

1/2019Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study.
12/2017Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.
3/2017Effects of levomilnacipran ER on noradrenergic symptoms, anxiety symptoms, and functional impairment in adults with major depressive disorder: Post hoc analysis of 5 clinical trials.
1/2017Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study.
11/2016Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder.
10/2016The efficacy of levomilnacipran ER across symptoms of major depressive disorder: a post hoc analysis of 5 randomized, double-blind, placebo-controlled trials.
3/2016Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
4/2015Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.
1/2015Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.
7/2014Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changzheng Chen Research Topics

Disease

21Major Depressive Disorder (Major Depressive Disorders)
01/2019 - 03/2013
4COVID-19
07/2021 - 01/2020
4Macular Degeneration (Age-Related Maculopathy)
06/2021 - 07/2004
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 09/2006
4Nausea
11/2018 - 01/2014
3Central Serous Chorioretinopathy
11/2020 - 01/2017
2Edema (Dropsy)
11/2021 - 01/2020
2Choroidal Neovascularization
11/2021 - 01/2015
2Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
11/2021 - 01/2020
2Retinoblastoma (Glioblastoma, Retinal)
01/2021 - 11/2020
2Macular Edema
01/2020 - 09/2006
2Headache (Headaches)
11/2018 - 01/2014
2Anxiety Disorders (Anxiety Disorder)
01/2017 - 01/2016
2Erectile Dysfunction
01/2016 - 01/2014
2Hyperhidrosis
02/2014 - 01/2014
2Dizziness (Lightheadedness)
02/2014 - 01/2014
2Constipation
02/2014 - 01/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2021
1Cataract (Cataracts)
01/2021
1Coinfection
01/2021
1Retinal Neovascularization
01/2021
1Glaucoma
01/2021
1Inflammation (Inflammations)
01/2021
1Hypertensive Retinopathy
01/2021
1Pathologic Neovascularization
01/2021
1Ischemia
10/2020
1Hemorrhage
04/2020
1Ganglion Cysts (Ganglion)
01/2020
1Acute-Phase Reaction
01/2020
1Optic Nerve Diseases (Optic Neuropathy)
01/2019
1Nasopharyngitis
11/2018
1Diarrhea
11/2018
1Cognitive Dysfunction
01/2017
1Fatigue
03/2016
1Medically Unexplained Symptoms
03/2016
1Mitochondrial Diseases (Mitochondrial Disease)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2016
1Diabetes Mellitus
01/2016
1Ejaculatory Dysfunction
01/2016
1Vomiting
02/2014
1Tachycardia (Tachyarrhythmias)
02/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
02/2014
1Hypertension (High Blood Pressure)
02/2014
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2006
1Epiretinal Membrane (Epiretinal Membranes)
09/2006
1Proliferative Vitreoretinopathy
09/2006
1Retinal Vein Occlusion
09/2006
1Retinal Perforations
09/2006
1Melanoma (Melanoma, Malignant)
03/2006
1Neovascular Glaucoma
09/2005

Drug/Important Bio-Agent (IBA)

16LevomilnacipranIBA
01/2019 - 03/2013
5Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 09/2004
5Retinaldehyde (Retinal)IBA
01/2021 - 01/2016
5Vilazodone HydrochlorideIBA
11/2018 - 01/2016
4Serotonin (5 Hydroxytryptamine)IBA
01/2019 - 10/2013
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019 - 10/2013
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2006 - 09/2004
2Immunoglobulin M (IgM)IBA
07/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
06/2021 - 11/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 01/2017
2Ranibizumab (Lucentis)FDA Link
01/2016 - 01/2015
1VincamineIBA
11/2021
1Hormones (Hormone)IBA
11/2021
1pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA
11/2021
1Immunoglobulin G (IgG)IBA
07/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Insulin Receptor Substrate ProteinsIBA
01/2021
1Circular RNAIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1human MIRN92 microRNAIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Silicone OilsIBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1AntigensIBA
01/2021
1Therapeutic UsesIBA
10/2020
1RNA (Ribonucleic Acid)IBA
08/2020
1yttrium-aluminum-garnetIBA
04/2020
1NeodymiumIBA
04/2020
1rho-Associated KinasesIBA
01/2020
1Y 27632IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Neuroprotective AgentsIBA
01/2020
1cariprazineIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2017
1Advanced Glycation End ProductsIBA
01/2016
1Fas Ligand Protein (Fas Ligand)IBA
01/2016
1advanced glycation end products-bovine serum albuminIBA
01/2016
1Fibrinogen (Factor I)FDA Link
01/2015
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
01/2014
1SuspensionsIBA
09/2006

Therapy/Procedure

3Photochemotherapy (Photodynamic Therapy)
11/2020 - 01/2017
3Intravitreal Injections
01/2020 - 09/2006
3Secondary Prevention
01/2019 - 01/2014
2Therapeutics
11/2021 - 01/2019
2Vitrectomy
01/2021 - 09/2006
1Nutrition Therapy (Medical Nutrition Therapy)
11/2021
1Solid-State Lasers
04/2020
1Lasers (Laser)
01/2020